Approval Year
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Official Name | English | ||
|
Code | English | ||
|
Code | English | ||
|
Code | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Code | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Code | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
FDA ORPHAN DRUG |
296609
Created by
admin on Mon Mar 31 20:02:40 GMT 2025 , Edited by admin on Mon Mar 31 20:02:40 GMT 2025
|
||
|
NCI_THESAURUS |
C20401
Created by
admin on Mon Mar 31 20:02:40 GMT 2025 , Edited by admin on Mon Mar 31 20:02:40 GMT 2025
|
||
|
FDA ORPHAN DRUG |
554216
Created by
admin on Mon Mar 31 20:02:40 GMT 2025 , Edited by admin on Mon Mar 31 20:02:40 GMT 2025
|
||
|
FDA ORPHAN DRUG |
533116
Created by
admin on Mon Mar 31 20:02:40 GMT 2025 , Edited by admin on Mon Mar 31 20:02:40 GMT 2025
|
||
|
FDA ORPHAN DRUG |
552216
Created by
admin on Mon Mar 31 20:02:40 GMT 2025 , Edited by admin on Mon Mar 31 20:02:40 GMT 2025
|
||
|
FDA ORPHAN DRUG |
403813
Created by
admin on Mon Mar 31 20:02:40 GMT 2025 , Edited by admin on Mon Mar 31 20:02:40 GMT 2025
|
||
|
FDA ORPHAN DRUG |
410913
Created by
admin on Mon Mar 31 20:02:40 GMT 2025 , Edited by admin on Mon Mar 31 20:02:40 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
DB11850
Created by
admin on Mon Mar 31 20:02:40 GMT 2025 , Edited by admin on Mon Mar 31 20:02:40 GMT 2025
|
PRIMARY | |||
|
100000168894
Created by
admin on Mon Mar 31 20:02:40 GMT 2025 , Edited by admin on Mon Mar 31 20:02:40 GMT 2025
|
PRIMARY | |||
|
U59UGK3IPC
Created by
admin on Mon Mar 31 20:02:40 GMT 2025 , Edited by admin on Mon Mar 31 20:02:40 GMT 2025
|
PRIMARY | |||
|
9334
Created by
admin on Mon Mar 31 20:02:40 GMT 2025 , Edited by admin on Mon Mar 31 20:02:40 GMT 2025
|
PRIMARY | |||
|
Ublituximab
Created by
admin on Mon Mar 31 20:02:40 GMT 2025 , Edited by admin on Mon Mar 31 20:02:40 GMT 2025
|
PRIMARY | |||
|
1174014-05-1
Created by
admin on Mon Mar 31 20:02:40 GMT 2025 , Edited by admin on Mon Mar 31 20:02:40 GMT 2025
|
PRIMARY | |||
|
C91078
Created by
admin on Mon Mar 31 20:02:40 GMT 2025 , Edited by admin on Mon Mar 31 20:02:40 GMT 2025
|
PRIMARY | |||
|
CD-90
Created by
admin on Mon Mar 31 20:02:40 GMT 2025 , Edited by admin on Mon Mar 31 20:02:40 GMT 2025
|
PRIMARY | |||
|
SUB182428
Created by
admin on Mon Mar 31 20:02:40 GMT 2025 , Edited by admin on Mon Mar 31 20:02:40 GMT 2025
|
PRIMARY | |||
|
CHEMBL2108354
Created by
admin on Mon Mar 31 20:02:40 GMT 2025 , Edited by admin on Mon Mar 31 20:02:40 GMT 2025
|
PRIMARY | |||
|
U59UGK3IPC
Created by
admin on Mon Mar 31 20:02:40 GMT 2025 , Edited by admin on Mon Mar 31 20:02:40 GMT 2025
|
PRIMARY |
ACTIVE MOIETY